Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000213258 | SCV000276409 | likely benign | Hereditary cancer-predisposing syndrome | 2015-06-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001084619 | SCV000632678 | likely benign | Juvenile polyposis syndrome | 2024-12-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000679545 | SCV000717697 | likely benign | not provided | 2019-06-27 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000679545 | SCV000806593 | likely benign | not provided | 2017-05-31 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000213258 | SCV002528548 | likely benign | Hereditary cancer-predisposing syndrome | 2021-04-03 | criteria provided, single submitter | curation | |
Color Diagnostics, |
RCV000213258 | SCV004360074 | likely benign | Hereditary cancer-predisposing syndrome | 2018-10-30 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV001084619 | SCV004835967 | likely benign | Juvenile polyposis syndrome | 2023-12-01 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV001084619 | SCV005404136 | benign | Juvenile polyposis syndrome | 2024-08-06 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |